Trial Profile
Phase II study of 7 days on/7 days off temozolomide in patients with high-grade glioma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Anaplastic astrocytoma; Astrocytoma; Glioblastoma; Glioma; Gliosarcoma
- Focus Therapeutic Use
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Oct 2007 New trial record.